Skip to content

Omnicell OMCL Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

Guardant Health logo
Guardant HealthGH
Fortive logo
FortiveFTV

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%
Enterprise value$1.54B-0.4%
P/E116.4×
P/S1.5×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's accrued progress collections and price adjustments?
Omnicell (OMCL) reported accrued progress collections and price adjustments of $63.07M in Q1 2026.
How has Omnicell's accrued progress collections and price adjustments changed year-over-year?
Omnicell's accrued progress collections and price adjustments decreased by 19.5% year-over-year, from $78.37M to $63.07M.
What is the long-term trend for Omnicell's accrued progress collections and price adjustments?
Over 5 years (2020 to 2025), Omnicell's accrued progress collections and price adjustments has grown at a 62.0% compound annual growth rate (CAGR), from $5.67M to $63.25M.